Movapo Pen (Apomorphine)

apomorphine hydrochloride hemihydrate 30 mg/3 mL injection, 5 x 3 mL pen devices · INJECTION · PBS code 14485J

STREAMLINED

What it costs

AU$129.4 PBS-determined price per 200 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2024-09-01.
• Repeats: 5.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Parkinson disease

Maintenance therapy

The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

Patient must have experienced severely disabling motor fluctuations which have not responded to other therapy; AND

Patient must have been commenced on treatment in a specialist unit in a hospital setting.

Sponsor: STADA Pharmaceuticals Australia Pty Limited ABN 73 154 966 944

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.